ESC 365 - Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction

ESC Professional Premium Access

Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction

Session: Lipids - Drug therapy 1

Topic: Drug therapy

Speaker: Professor R. Rosenson (New York, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Robert Rosenson

Icahn School of Medicine at Mount Sinai, New York (United States of America)

2 presentations

0 follower

5 more presentations in this session

Correlation of lipoprotein (a) with parameters of lipid profile and other cardiovascular risk factors in patients with familial combined hyperlipidemia

Speaker: Doctor I. Andrikou (Athens, GR)

Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab

Speaker: Doctor T. Michaeli (Mannheim, DE) Doctor D. Michaeli (Mannheim, DE)

Simulation of bempedoic acid in the lipid-lowering treatment pathway using the European contemporary SANTORINI cohort of high- and very high-risk patients

Speaker: Doctor A. Bilitou (Munich, DE)

PCSK9 inhibitors: effectiveness of treatment and changes in background lipid-lowering therapy in a real world Italian population. The AT-TARGET-IT study

Speaker: Doctor C. Basile (Naples, IT)

Worldwide comparative efficacy of nutraceuticals on lipid profile. an updated systematic review and network meta-analysis

Speaker: Doctor T. Osadnik (Zabrze, PL)

Access the full session

Lipids - Drug therapy 1

Speakers: Professor R. Rosenson, Doctor I. Andrikou, Doctor T. Michaeli, Doctor D. Michaeli, Doctor A. Bilitou...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources